How Lundbeck’s CEO aims to keep firm ‘punching above its weight’
Almost three years into his tenure as Lundbeck’s CEO, Charl van Zyl is confident the company can prove…
FDA approvals outrun staff cuts: 23 novel drugs mark the best first half in three years – Endpoints News
FDA approvals outrun staff cuts: 23 novel drugs mark the best first half in three years Endpoints News FDA…
Tips to help choose over-the-counter medications safely and wisely – The Irish Times
Over-the-counter (OTC) medications help people cure some simple diseases easily and without seeing a doctor. Some OTC drugs…
Emcure reduces price of weight management drug Poviztra by 55%
Emcure reduces price of weight management drug Poviztra by 55% April 02, 2026 | Thursday | News Price…
Boston to curb insurance coverage of GLP-1 drugs for city workers
The PEC voted unanimously on Tuesday to let the city change its Blue Cross Blue Shield of Massachusetts…
India’s coming Ozempic moment could reshape both waistlines and perceptions
On a recent episode of CBS Sports Golazo, Clint Dempsey couldn’t resist a dig. Sitting alongside Thierry Henry,…
Don't advertise weight-loss drugs: Govt to pharma firms | 'Obesity 'awareness campaigns' also misleading' | Inshorts – Inshorts
Don’t advertise weight-loss drugs: Govt to pharma firms | ‘Obesity ‘awareness campaigns’ also misleading’ | Inshorts Inshorts India warns…
What Big Pharma Won’t Tell You: The Ancient Natural Remedy People Swear By — and It Costs Almost Nothing
Claims that “Big Pharma doesn’t want you to know” about a powerful, nearly free natural remedy circulate widely…
NHS must keep medicine rebate down or lose investment
Wednesday 18 February 2026 2:27 pm | Updated: Wednesday 18 February 2026 3:10 pm Share Facebook Share on Facebook…
Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial – Endpoints News
Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial Endpoints News Roche unveils data behind BTK inhibitor’s phase…